Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity

Journal of Autoimmunity

Volumn 37, Issue 3, 2011, Pages 209-216

  Naiyanetr, Phornnop ^a,f   Butler, Jeffrey D ^b   Meng, Liping ^a,b   Pfeiff, Janice ^b   Kenny, Thomas P ^a   Guggenheim, Kathryn G ^b   Reiger, Roman ^a   Lam, Kit ^a   Kurth, Mark J ^b   Ansari, Aftab A ^c   Coppel, Ross L ^d   López Hoyos, Marcos ^e   Gershwin, M Eric ^a   Leung, Patrick S C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MONASH UNIVERSITY   (Australia)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anti mitochondrial antibodies; Primary biliary cirrhosis; Pyruvate dehydrogenase; Xenobiotics

Indexed keywords

2 OCTYNOIC ACID; 6,8 BIS(ACETYLTHIO)OCTANOIC ACID; DISULFIDE; ELECTROPHILE; IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY; OCTANOIC ACID; PYRUVATE DEHYDROGENASE COMPLEX; THIOCTIC ACID; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON TRANSPORT; HUMAN; IMMUNOREACTIVITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN MICROARRAY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ACETAMINOPHEN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CATTLE; CHOLANGITIS; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, MONOUNSATURATED; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIVER CIRRHOSIS, BILIARY; MICE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PROTEIN STRUCTURE, TERTIARY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SERUM ALBUMIN; THIOCTIC ACID;

EID: 80755133531     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.06.001     Document Type: Article

References (43)

1. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun 2010, 34:J300-J306.
2. Gershwin M.E., Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008, 47:737-745.
3. Agmon-Levin N., Shapira Y., Selmi C., Barzilai O., Ram M., Szyper-Kravitz M., et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 2010, 34:55-58.
4. Rieger R., Gershwin M.E. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007, 28:76-84.
5. Tiegs G., Lohse A.W. Immune tolerance: what is unique about the liver. J Autoimmun 2010, 34:1-6.
6. Carambia A., Herkel J. CD4 T cells in hepatic immune tolerance. J Autoimmun 2010, 34:23-28.
7. Christen U., Hintermann E., Holdener M., von Herrath M.G. Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?. J Autoimmun 2010, 34:38-44.
8. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:J168-J177.
9. McNally R.J., Ducker S., James O.F. Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis. Hepatology 2009, 50:1169-1174.
10. Amano K., Leung P.S., Rieger R., Quan C., Wang X., Marik J., et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005, 174:5874-5883.
11. Rieger R., Leung P.S., Jeddeloh M.R., Kurth M.J., Nantz M.H., Lam K.S., et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 2006, 27:7-16.
12. Wakabayashi K., Yoshida K., Leung P.S., Moritoki Y., Yang G.X., Tsuneyama K., et al. Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin Exp Immunol 2009, 155:577-586.
13. Wakabayashi K., Lian Z.X., Leung P.S., Moritoki Y., Tsuneyama K., Kurth M.J., et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008, 48:531-540.
14. Leung P.S., Park O., Tsuneyama K., Kurth M.J., Lam K.S., Ansari A.A., et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 2007, 179:2651-2657.
15. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
16. Bambha K., Kim W.R., Talwalkar J., Torgerson H., Benson J.T., Therneau T.M., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003, 125:1364-1369.
17. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
18. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
19. Leung P.S., Quan C., Park O., Van de Water J., Kurth M.J., Nantz M.H., et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003, 170:5326-5332.
20. Amano K., Leung P.S., Xu Q., Marik J., Quan C., Kurth M.J., et al. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol 2004, 172:6444-6452.
21. Xu Q., Miyamoto S., Lam K.S. A novel approach to chemical microarray using ketone-modified macromolecular scaffolds: application in micro cell-adhesion assay. Mol Divers 2004, 8:301-310.
22. Bragd P.L., Besemer A.C., van Bekkum H. Bromide-free TEMPO-mediated oxidation of primary alcohol groups in starch and methyl alpha-D-glucopyranoside. Carbohydr Res 2000, 328:355-363.
23. Christensen T. A chloranil color test for monitoring coupling completeness in solid phase peptide synthesis 1979, Pierce Chemical Co., Rockford, IL.
24. Lemieux G.A., Bertozzi C.R. Chemoselective ligation reactions with proteins, oligosaccharides and cells. Trends Biotechnol 1998, 16:506-513.
25. Shao J., Tam J.P. Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone, and thiazolidine linkages. J Am Chem Soc 1995, 117:3893-3899.
26. Long S.A., Quan C., Van de Water J., Nantz M.H., Kurth M.J., Barsky D., et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001, 167:2956-2963.
27. Kaiser E., Colescott R.L., Bossinger C.D., Cook P.I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 1970, 34:595-598.
28. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Gu X., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-2555.
29. Invernizzi P., Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 2009, 33:290-299.
30. Chang C., Gershwin M.E. Drugs and autoimmunity-a contemporary review and mechanistic approach. J Autoimmun 2010, 34:J266-J275.
31. Leung P.S., Rossaro L., Davis P.A., Park O., Tanaka A., Kikuchi K., et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007, 46:1436-1442.
32. David Josephy P. The molecular toxicology of acetaminophen. Drug Metab Rev 2005, 37:581-594.
33. Rossi L., McGirr L.G., Silva J., O'Brien P.J. The metabolism of N-acetyl-3,5-dimethyl-p-benzoquinone imine in isolated hepatocytes involves N-deacetylation. Mol Pharmacol 1988, 34:674-681.
34. Larson A.M. Acetaminophen hepatotoxicity. Clin Liver Dis 2007, 11:525-548. vi.
35. Mao T.K., Davis P.A., Odin J.A., Coppel R.L., Gershwin M.E. Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology 2004, 40:1241-1248.
36. Odin J.A., Huebert R.C., Casciola-Rosen L., LaRusso N.F., Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001, 108:223-232.
37. Lleo A., Selmi C., Invernizzi P., Podda M., Coppel R.L., Mackay I.R., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009, 49:871-879.
38. Lleo A., Bowlus C.L., Yang G.X., Invernizzi P., Podda M., Van de Water J., et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010, 52:987-998.
39. Barak V., Selmi C., Schlesinger M., Blank M., Agmon-Levin N., Kalickman I., et al. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. J Autoimmun 2009, 33:178-182.
40. Lleo A., Shimoda S., Ishibashi H., Gershwin M.E. Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol 2010.
41. Benson G.D., Kikuchi K., Miyakawa H., Tanaka A., Watnik M.R., Gershwin M.E. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin Dev Immunol 2004, 11:129-133.
42. Mattalia A., Luttig B., Rosina F., Leung P.S., Van de Water J., Bauducci M., et al. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis. J Autoimmun 1997, 10:491-497.
43. Ohmori H., Kanayama N. Mechanisms leading to autoantibody production: link between inflammation and autoimmunity. Curr Drug Targets Inflamm Allergy 2003, 2:232-241.